Concept Medical Inc. is proud to announce the successful enrollment of the first patients in the STARS DAPT randomized ...

A new randomized clinical trial has revealed that just 24 minutes of listening to specially designed music paired with ...

SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...

Specialty CNS Research Center Strengthens Trial Execution and Patient Diversity in Alzheimer's Agitation Study - POTOMAC, MD / ACCESS Newswire / January 22, 2026 /IGC Pharma, Inc. (NYSE American:IGC) ...

An interactive smart speaker intervention reduced mental distress and improved diabetes-related outcomes in older adults with type 2 diabetes. Participants using the virtual assistant showed ...

Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.

For optometrists, 2026 provides ample opportunity to continue the charge in advancements in dry eye, artificial intelligence ...

A new study by UCLA and Kaiser Permanente Northwest's Center for Health Research demonstrates a health care approach matching treatment intensity to individual risk levels can significantly reduce ...

A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and resulted in fewer side effects among people with head and neck cancer. The ...

In certain cases, regulators will now be open to clearing therapies based on their ability to eliminate tumor cells, a change ...

The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...

Multi-Specialty CNS Research Center Strengthens Trial Execution and Patient Diversity in Alzheimer's Agitation Study - POTOMAC, MD / ACCESS Newswire / January 22, 2026 / IGC Pharma, Inc. (NYSE America ...